SER
Serina Therapeutics, Inc.Closed1.82−0.12 −6.19%USD
NYSE American · as of Oct 13, 16:00 ETAfter hours 1.82 0.00%
Open
1.92
Prev close
1.94
Day range
1.781.97
52-week range
1.225.29
Volume
26.33K0.40×
Mkt cap
46.23M
P/E ttm
—
Fwd P/E
-1.73
EPS ttm
-1.87
Div yield
0.00%
Earnings
—
From 52w high
−65.60%
SER earnings and estimates
SER Next Report
Yahoo Finance · Nasdaq
No upcoming report date is published for SER.
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 13, 2026 AMC | −0.52 | −0.35 | −49.71% | — | −1.8% | −7.0% |
| Mar '26 | May 14, 2026 AMC | −0.53 | −0.44 | −19.77% | $0 | −4.7% | +9.7% |
| Dec '25 | Mar 25, 2026 AMC | −0.31 | −0.50 | +38.00% | $0 | −13.9% | −30.0% |
| Sep '25 | Nov 13, 2025 BMO | −0.51 | −0.53 | +3.11% | $0 | −2.5% | −3.9% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.34 | −0.37−0.31 | +24.4% | $0 | 0.0% | −0.49 +30.6% | −0.46 +26.1% | 2 / 0 |
| Next quarter Dec 2026 | −0.30 | −0.33−0.27 | +3.2% | $0 | 0.0% | −0.43 +31.0% | −0.38 +21.1% | 2 / 0 |
| Current year Dec 2026 | −1.58 | −1.76−1.40 | +17.3% | $0 | −100.0% | −1.95 +19.0% | −1.84 +14.1% | 2 / 0 |
| Next year Dec 2027 | −1.16 | −1.33−0.98 | +26.9% | $0 | 0.0% | −1.57 +26.4% | −1.26 +8.3% | 2 / 0 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.